NCT01949103View on ClinicalTrials.gov

TD-1607 MAD Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
InfectionsBacterial Infections
Interventions
DRUG

TD-1607

DRUG

Placebo

Trial Locations (1)

78744

PPD, Phase 1 Clinic, Austin

Sponsors
All Listed Sponsors
lead

Theravance Biopharma

INDUSTRY